Skip to Content

Hormone Therapy May Reduce Nocturia After Menopause

TUESDAY, March 23, 2021 -- The percentage of postmenopausal women experiencing nocturia two or more times per night was lower among those who selected systemic hormone treatment compared with no treatment, according to a study published online March 15 in Menopause.

Kim Pauwaert, M.D., from Ghent University Hospital in Belgium, and colleagues assessed the impact of different hormonal treatment options on nocturia. The analysis included 245 postmenopausal women given the treatment of their choice: estrogen plus progesterone (E+P), estrogen only in patients with a prior hysterectomy, tissue-selective estrogen complex (TSEC), or no treatment.

The researchers found a significant reduction in the prevalence of nocturia twice a night or more after treatment. The prevalence of nocturia decreased from 27.7 to 16.4 percent. Patients treated with E+P and TSEC saw significant reductions in nocturnal voiding frequency. There were also significant reductions seen in the SLEEP sum score in patients treated with E+P and TSEC. There was a significant change in the URINARY TRACT sum score as a result of a reduction in urgency prevalence among women treated with estrogen only.

"This pilot study demonstrated a significant reduction in nocturia and its associated bother when different hormone treatment options were given for six months," the authors write.

One author disclosed financial ties to pharmaceutical and medical companies and is also a shareholder and cofounder of P2S.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Factors Identified to Help Predict Age at Menopause

MONDAY, April 19, 2021 -- Higher levels of estradiol and follicle-stimulating hormone, irregular menstrual cycles, and symptoms of menopause are strong indicators that a woman is...

Belly Fat Gain During Menopause May Elevate CVD Risk

FRIDAY, April 2, 2021 -- Women experience an accelerated increase in visceral adipose tissue (VAT) starting two years before menopause, which is associated with a greater risk for...

Premature Ovarian Insufficiency Tied to More Menopausal Symptoms

MONDAY, Feb. 1, 2021 -- Women with premature ovarian insufficiency (POI) experience a high prevalence of menopausal symptoms, according to a study published online Jan. 18 in...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.